Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Cytotherapy|December 9, 2024
Comparison of methotrexate dosing protocols for graft-versus-host disease prophylaxis after unrelated hematopoietic stem cell transplantationNaokazu Nakamura, Junya Kanda, Tadakazu Kondo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 2, 2020
Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation for Mature T Cell and Natural Killer Cell Neoplasms in the Kyoto Stem Cell Transplantation GroupMizuki Watanabe, Junya Kanda, Yasuyuki Arai, et al.
Bone Marrow Transplantation|March 3, 2022
Coexistence of HLA and KIR ligand mismatches as a risk factor for viral infection early after cord blood transplantationTomoki Iemura, Yasuyuki Arai, Toshio Kitawaki, et al.
The Journal of Rheumatology|December 17, 2013
A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disordersNoriyuki Yamakawa, Masakazu Fujimoto, Daisuke Kawabata, et al.
Transplantation|December 22, 2021
Single Cord Blood Transplantation Versus HLA-Haploidentical-related Donor Transplantation Using Posttransplant Cyclophosphamide in Patients With Hematological MalignanciesFumiya Wada, Junya Kanda, Satoshi Yoshioka, et al.
Blood Advances|December 21, 2021
Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learningMakoto Iwasaki, Junya Kanda, Yasuyuki Arai, et al.
Annals of Hematology|April 13, 2023
Effects of combined test dose and therapeutic drug monitoring strategy in exposure-directed busulfanTomoki Iemura, Tadakazu Kondo, Atsushi Ueda, et al.
Cell Transplantation|August 30, 2023
Mild Acute Graft-Versus-Host Disease Improves Outcomes After HLA-Haploidentical-Related Donor Transplantation Using Posttransplant Cyclophosphamide and Cord Blood TransplantationFumiya Wada, Junya Kanda, Kimimori Kamijo, et al.
Hematology (Amsterdam, Netherlands)|February 14, 2022
Bortezomib-cyclophosphamide-dexamethasone induction/consolidation and bortezomib maintenance for transplant-eligible newly diagnosed multiple myeloma: phase 2 multicenter trialHiroyuki Muranushi, Junya Kanda, Masayuki Kobayashi, et al.
Leukemia|January 7, 2026
NUP98 rearrangements in adult AML patients: evaluation of clinical implications and identification of novel fusion partnersKazuhisa Chonabayashi, Makoto Iwasaki, Junya Kanda, et al.
Pageof 9